Literature DB >> 25005877

Neuronal NAMPT is released after cerebral ischemia and protects against white matter injury.

Zheng Jing1, Juan Xing1, Xinzhi Chen1, Ruth A Stetler2, Zhongfang Weng2, Yu Gan2, Feng Zhang2, Yanqin Gao3, Jun Chen1, Rehana K Leak4, Guodong Cao1.   

Abstract

Nicotinamide phosphoribosyltransferase (NAMPT) has been implicated in neuroprotection against ischemic brain injury, but the mechanism underlying its protective effect remains largely unknown. To further examine the protective effect of NAMPT against ischemic stroke and its potential mechanism of action, we generated a novel neuron-specific NAMPT transgenic mouse line. Transgenic mice and wild-type littermates were subjected to transient occlusion of the middle cerebral artery (MCAO) for 60 minutes. Neuron-specific NAMPT overexpression significantly reduced infarct volume by 65% (P=0.018) and improved long-term neurologic outcomes (P≤0.05) compared with littermates. Interestingly, neuronal overexpression of NAMPT increased the area of myelinated fibers in the striatum and corpus callosum, indicating that NAMPT protects against white matter injury. The mechanism of protection appeared to be through extracellular release of NAMPT. First, NAMPT was secreted into the extracellular medium by primary cortical neurons exposed to ischemia-like oxygen-glucose deprivation (OGD) in vitro. Second, conditioned medium from NAMPT-overexpressing neurons exposed to OGD protected cultured oligodendrocytes from OGD. Third, the protective effects of conditioned medium were abolished by antibody-mediated NAMPT depletion, strongly suggesting that the protective effect is mediated by the extracellular NAMPT released into in the medium. These data suggest a novel neuroprotective role for secreted NAMPT in the protection of white matter after ischemic injury.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25005877      PMCID: PMC4269719          DOI: 10.1038/jcbfm.2014.119

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  27 in total

1.  Cerebral white matter is highly vulnerable to ischemia.

Authors:  L Pantoni; J H Garcia; J A Gutierrez
Journal:  Stroke       Date:  1996-09       Impact factor: 7.914

2.  Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1-dependent adenosine monophosphate-activated kinase pathway.

Authors:  Pei Wang; Tian-Ying Xu; Yun-Feng Guan; Wei-Wei Tian; Benoit Viollet; Yao-Cheng Rui; Qi-Wei Zhai; Ding-Feng Su; Chao-Yu Miao
Journal:  Ann Neurol       Date:  2011-01-19       Impact factor: 10.422

3.  Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme.

Authors:  Javier R Revollo; Antje Körner; Kathryn F Mills; Akiko Satoh; Tao Wang; Antje Garten; Biplab Dasgupta; Yo Sasaki; Cynthia Wolberger; R Reid Townsend; Jeffrey Milbrandt; Wieland Kiess; Shin-Ichiro Imai
Journal:  Cell Metab       Date:  2007-11       Impact factor: 27.287

4.  White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion.

Authors:  Masunari Shibata; Ryo Ohtani; Masafumi Ihara; Hidekazu Tomimoto
Journal:  Stroke       Date:  2004-10-07       Impact factor: 7.914

5.  In Vivo Delivery of a Bcl-xL Fusion Protein Containing the TAT Protein Transduction Domain Protects against Ischemic Brain Injury and Neuronal Apoptosis.

Authors:  Guodong Cao; Wei Pei; Hailiang Ge; Qinhua Liang; Yumin Luo; Frank R Sharp; Aigang Lu; Ruiqiong Ran; Steven H Graham; Jun Chen
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

6.  Temporal and spatial dynamics of cerebral immune cell accumulation in stroke.

Authors:  Mathias Gelderblom; Frank Leypoldt; Karin Steinbach; Doerthe Behrens; Chi-Un Choe; Dominic A Siler; Thiruma V Arumugam; Ellen Orthey; Christian Gerloff; Eva Tolosa; Tim Magnus
Journal:  Stroke       Date:  2009-03-05       Impact factor: 7.914

Review 7.  The NAD World: a new systemic regulatory network for metabolism and aging--Sirt1, systemic NAD biosynthesis, and their importance.

Authors:  Shin-Ichiro Imai
Journal:  Cell Biochem Biophys       Date:  2009       Impact factor: 2.194

8.  Remyelination can be extensive in multiple sclerosis despite a long disease course.

Authors:  R Patani; M Balaratnam; A Vora; R Reynolds
Journal:  Neuropathol Appl Neurobiol       Date:  2007-04-18       Impact factor: 8.090

9.  Tissue plasminogen activator prevents white matter damage following stroke.

Authors:  Fernando Correa; Maxime Gauberti; Jérôme Parcq; Richard Macrez; Yannick Hommet; Pauline Obiang; Miriam Hernangómez; Axel Montagne; Géraldine Liot; Carmen Guaza; Eric Maubert; Carine Ali; Denis Vivien; Fabian Docagne
Journal:  J Exp Med       Date:  2011-05-16       Impact factor: 14.307

10.  Isolation and partial characterization of the human homologue of Thy-1.

Authors:  E W Ades; R K Zwerner; R T Acton; C M Balch
Journal:  J Exp Med       Date:  1980-02-01       Impact factor: 14.307

View more
  26 in total

Review 1.  The brain, sirtuins, and ageing.

Authors:  Akiko Satoh; Shin-Ichiro Imai; Leonard Guarente
Journal:  Nat Rev Neurosci       Date:  2017-05-18       Impact factor: 34.870

2.  Evaluation of the NAD+ biosynthetic pathway in ALS patients and effect of modulating NAD+ levels in hSOD1-linked ALS mouse models.

Authors:  Benjamin A Harlan; Kelby M Killoy; Mariana Pehar; Liping Liu; Johan Auwerx; Marcelo R Vargas
Journal:  Exp Neurol       Date:  2020-01-31       Impact factor: 5.330

3.  Reduced brain edema and infarct volume in aquaporin-4 deficient mice after transient focal cerebral ischemia.

Authors:  Xiaoming Yao; Nikita Derugin; Geoffrey T Manley; A S Verkman
Journal:  Neurosci Lett       Date:  2014-11-01       Impact factor: 3.046

Review 4.  The Role of Nicotinamide Phosphoribosyltransferase in Cerebral Ischemia.

Authors:  Xinzhi Chen; Shangfeng Zhao; Yang Song; Yejie Shi; Rehana K Leak; Guodong Cao
Journal:  Curr Top Med Chem       Date:  2015       Impact factor: 3.295

5.  Intracerebroventricular Delivery of Recombinant NAMPT Deters Inflammation and Protects Against Cerebral Ischemia.

Authors:  Fenghua Chen; Zhongfang Weng; Qinghai Xia; Catherine Cao; Rehana K Leak; Lihong Han; Jian Xiao; Steven H Graham; Guodong Cao
Journal:  Transl Stroke Res       Date:  2019-02-28       Impact factor: 6.829

Review 6.  Nicotinamide Adenine Dinucleotide Metabolism and Neurodegeneration.

Authors:  Mariana Pehar; Benjamin A Harlan; Kelby M Killoy; Marcelo R Vargas
Journal:  Antioxid Redox Signal       Date:  2017-06-27       Impact factor: 8.401

Review 7.  Role of NAD+ and FAD in Ischemic Stroke Pathophysiology: An Epigenetic Nexus and Expanding Therapeutic Repertoire.

Authors:  Parimala Narne; Prakash Babu Phanithi
Journal:  Cell Mol Neurobiol       Date:  2022-09-30       Impact factor: 4.231

Review 8.  White matter injury in ischemic stroke.

Authors:  Yuan Wang; Gang Liu; Dandan Hong; Fenghua Chen; Xunming Ji; Guodong Cao
Journal:  Prog Neurobiol       Date:  2016-04-14       Impact factor: 11.685

Review 9.  Physiological and pathophysiological roles of NAMPT and NAD metabolism.

Authors:  Antje Garten; Susanne Schuster; Melanie Penke; Theresa Gorski; Tommaso de Giorgis; Wieland Kiess
Journal:  Nat Rev Endocrinol       Date:  2015-07-28       Impact factor: 43.330

10.  Nicotinamide mononucleotide inhibits post-ischemic NAD(+) degradation and dramatically ameliorates brain damage following global cerebral ischemia.

Authors:  Ji H Park; Aaron Long; Katrina Owens; Tibor Kristian
Journal:  Neurobiol Dis       Date:  2016-07-15       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.